Back to Journals » Lung Cancer: Targets and Therapy » Volume 7

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

Total article views   HTML views PDF downloads Totals
9,440 Dovepress* 8,276+ 1,583 9,859
PubMed Central* 1,164 323 1,487
Totals 9,440 1,906 11,346
*Since 17 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed and Google Scholar